ARTICLE
Auteur(s) : Heike Andrea Lörcher, Nina Booken, Astrid
Schmieder, Sergij Goerdt, Matthias
Goebeler
Department of Dermatology, University Hospital Mannheim,
University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68135
Mannheim, Germany
In spring 2007, a 47-year-old woman presented at our Department
with a 4-day history of a painful papular-purpuric erythema of
palmae, plantae and dorsal surfaces of the hands and feet (figure 1). Five days
before, she had experienced oropharyngeal pain and odynophagia. She
reported the occurrence of similar skin lesions 2 years before.
Apart from her acral purpuric-petechial rash, the patient presented
in a good general condition. Mucosal membranes were not affected.
A punch biopsy obtained from the left palm showed a
superficial dermal lymphocytic infiltrate (figure 1D). Direct
immunofluorescence was unremarkable. Laboratory tests revealed
lymphopenia and a moderate elevation of alkaline phosphatase,
gamma-glutamyl transpeptidase, lactate dehydrogenase and C-reactive
protein. Serology showed IgG antibodies to CMV, EBV, HHV6,
enteroviruses and Parvovirus B19, while IgM antibodies were not
detectable. Blood tests for viral hepatitis A, B and C were
negative. The diagnosis of papular-purpuric gloves and socks
syndrome (PPGSS) was made and symptomatic treatment initiated. Skin
lesions completely resolved within a few weeks.
One year later, in spring 2008, the patient presented again with
purpuric lesions in a “gloves and socks” distribution.
Additionally, petechial lesions on the palate were visible. There
was no history of preceding infection. Repetition of serological
tests revealed, as compared to the episode before, considerably
increased levels of IgG antibodies to Parvovirus B19, while all
other above mentioned viral antibody titres remained unchanged. IgM
antibodies against Parvovirus B19 or other viruses were not
detectable. The patient’s skin lesions completely resolved upon
symptomatic treatment within two weeks.
PPGSS is a rare, self-limited exanthema characterized by sharply
margined erythematopapular and purpuric lesions of the hands and
feet in a “gloves and socks” distribution that are often pruritic
and sometimes painful [1-3]. In about half of cases similar lesions
occur at other sites, such as the cheeks, elbows, buttocks and
thighs. Oral mucosal involvement is frequently observed. General
symptoms such as fever, asthenia, anorexia, arthralgia, myalgia and
lymphadenopathy may occur simultaneously with the skin lesions and
are usually mild and transient. Histopathological findings in fully
evolved PPGSS include vacuolar interface changes associated with
necrotic keratinocytes and dermal haemorrhage [4]. Early
histological changes are, as in our patient, non-specific, showing
a superficial perivascular lymphocytic infiltrate. Laboratory
findings are variable and may include leukopenia, neutropenia,
monocytosis and mild elevation of transaminases and C-reactive
protein.
Since its first description in 1990 by Harms et al. [1], only
about 80 cases of PPGSS have been reported, which mainly occurred
in young adults during spring and summer months [2]. In 50% of
these, PPGSS was attributed to infection with Parvovirus B19 [5,
6]. In most of these cases clinical manifestations were due to
primary infection, while reinfection or reactivation were rare [6].
Relapsing PPGSS, as reported here, has not been communicated
before. Besides Parvovirus B19, other agents such as CMV, measles
and rubella viruses, Coxsackie virus B6, EBV, HHV6, HHV7 and
hepatitis B virus, bacteria (Arcanobacterium haemolyticum) and
drugs (trimethoprim sulfamethoxazole) have been associated with
PPGSS.
While the trigger of our patient’s PPGSS could not definitely be
proven and other etiological agents were not identified, we assume
that it might most likely be due to Parvovirus B19. Detection of
IgG antibodies at the initial presentation may refer to a primary
infection possibly two years before, when PPGSS-like skin lesions
occurred for the first time. It remained unclear, however, whether
persisting latent infection of intracellular compartments that are
not accessible for protecting antibodies was responsible for the
recurrence of PPGSS. Finally, we can not exclude that another agent
elicited one of the PPGSS episodes. In conclusion, our case report
illustrates that PPGSS may, on rare occasions, episodically
recur.
Acknowledgements
Financial support: none. Conflict of interest: none.
References
1 Harms M, Feldmann R, Saurat JH. Papular-purpuric
‘gloves and socks’ syndrome. J Am Acad Dermatol 1990; 23: 850-4.
2 Veraldi S, Rizitelli G, Scarabelli G,
Gelmetti C. Papular-purpuic ‘gloves and socks’ syndrome. Arch
Dermatol 1996; 132: 975-7.
3 Borradori L, Cassinotti P, Perrenoud D,
Frenk E. Papular-purpuric ‘gloves and socks’ syndrome. Int J
Dermatol 1994; 33: 196-7.
4 Smith SB, Libow LF, Elston DM, Bernert RA,
Warschaw KE. Gloves and socks syndrome: Early and late
histopathologic features. J Am Acad Dermatol 2002; 47: 749-54.
5 Bagot M, Revuz J. Papular-purpuric ‘gloves and
socks’ syndrome: primary infection with parvovirus B19? J Am Acad
Dermatol 1991; 25: 341-2.
6 Feldmann R, Harms M, Saurat JH.
Papular-purpuric ‘gloves and socks’ syndrome: not only parvovirus
B19. Dermatology 1994; 188: 85-7.
|